← Back to Search

Other

Oral Dissolvable Tablet Zofran (OZ) for Vomiting (VOMIITED Trial)

Phase < 1
Waitlist Available
Led By Scott Crawford, MD
Research Sponsored by Texas Tech University Health Sciences Center, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Patients aged 18-65 years presenting to the emergency department complaining of current nausea with or without episodes of emesis beginning within the previous 24hrs
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the two methods to see which is more effective.

Eligible Conditions
  • Vomiting
  • Nausea

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Nausea Severity
Secondary study objectives
Emesis Event

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Oral Dissolvable Tablet Zofran (OZ)Experimental Treatment1 Intervention
4 mg Oral Dissolvable Tablet Zofran (ondansetron)
Group II: Inhaled Isopropyl Alcohol (IPA)Active Control1 Intervention
Inhaled Isopropyl Alcohol (alcohol prep pad)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oral Dissolvable Tablet Zofran (ondansetron)
2017
Completed Early Phase 1
~130

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences Center, El PasoLead Sponsor
49 Previous Clinical Trials
4,961 Total Patients Enrolled
Scott Crawford, MD5.01 ReviewsPrincipal Investigator - Texas Tech Universtiy Health Sciences Center El Paso
Texas Tech University Health Sciences Center, El Paso
~15 spots leftby Nov 2025